Patent · US Active

Therapeutic compounds and formulations for intranasal delivery

US10682310B2 · kind B2 · utility

0Cited by

2References

2Claims

0Family size

Assignee

Regents of the University of Minnesota · US

Inventors

Ronald A. Siegel · Minneapolis, US
Mamta Kapoor · Minneapolis, US
Narsihmulu Cheryala · Minneapolis, US
Gunda I. Georg · Minneapolis, US
James C. Cloyd · Austin, US

Key dates

Filing date	Mar 17, 2016
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Jun 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21063
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain embodiments of the invention provide a formulation suitable for nasal administration comprising water, a prodrug of a therapeutic agent, and an enzyme that is suitable for intranasal conversion of the prodrug to the therapeutic agent, as well as methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.